Search company, investor...

KINAXO Biotechnologies

kinaxo.de

Founded Year

2006

Stage

Acquired | Acquired

About KINAXO Biotechnologies

KINAXO Biotechnologies supports pharmaceutical and biotechnology companies in search for selective kinase drugs.In April 2011, KINAXO Biotechnologies was acquired by Evotec AG. The valuaton of KINAXO Biotechnologies was undisclosed. Other terms of the deal were not released.

Headquarters Location

Am Klopferspitz 19a

82152,

Germany

Missing: KINAXO Biotechnologies's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: KINAXO Biotechnologies's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

KINAXO Biotechnologies Frequently Asked Questions (FAQ)

  • When was KINAXO Biotechnologies founded?

    KINAXO Biotechnologies was founded in 2006.

  • What is KINAXO Biotechnologies's latest funding round?

    KINAXO Biotechnologies's latest funding round is Acquired.

  • Who are the investors of KINAXO Biotechnologies?

    Investors of KINAXO Biotechnologies include Evotec, Mountain Partners, BioM Venture Capital & Fonds, KfW, High-Tech Grunderfonds and 3 more.

  • Who are KINAXO Biotechnologies's competitors?

    Competitors of KINAXO Biotechnologies include Longevica, Molmed, Bloomage BioTech, Array Biopharma, Advanced Analytical Technologies and 12 more.

Compare KINAXO Biotechnologies to Competitors

A
Angel Biotechnology

Angel Biotechnology Holdings PLC (AIM: ABH) is a world class, contract biomanufacturing company offering process development services and pre-GMP and cGMP manufacturing to support biotechnology and pharmaceutical companies worldwide. Angel's principal activity is the manufacture and supply of materials for use in early stage drug development and pre-clinical studies, along with drug product and CMC documentation for Phases I, II and III clinical trials and the manufacture of licensed drugs or vaccines. nnAngel is managed by a team that has more than 100 years' combined experience in pharmaceutical and biopharmaceutical manufacture, gained in companies such as Glaxo and Serologicals Inc. nnAngel operates out of Pentlands Science Park, near Edinburgh.

R
Recoly

Recoly N.V., a Netherlands Antilles based biotechnology company, is in the business of developing or acquiring platform technologies for use in the health care industry. Through the efforts of its research and development team, Recoly has developed a patented, platform technology which has been shown to prolong the half-life and improve the biological efficacy of protein and peptide pharmaceuticals by formulating them with PEGylated liposomes. The proteins and peptides bind non-covalently and yet with high affinity to the external surface of the liposomes; the proteins and peptides maintain their biological activity. No change in the protein/peptide manufacturing process is required. Recoly's business model is to partner with pharmaceutical and biotechnology companies to develop improvements of approved pharmaceutical products and thereby extend product franchises and enlarge product pipelines.

P
Pi Proteomics

Pi Proteomics LLC manufactures custom and catalog peptides for academia, the biotechnology industry, antibody companies and the pharma industry.

C
Clal Biotechnology Industries

Clal Biotechnology Industries is a public investment firm targeting pre-clinical, seed, start-up, early venture, emerging growth and growth capital stages of financing that was founded in 1998 and based in Tel Aviv, Israel. Clal primarily invests in biopharmaceutical and biotech companies. Generally, Clal Biotechnogy Industries looks to invest up to $10 million per company and prefers to be lead investor and take a board seat. It also seeks to take a majority share in its portfolio companies.

M
MODA Technology Partners

MODA Technology Partners is a provider of informatics solutions for pharmaceutical and biotechnology quality manufacturing

Plexus Ventures Logo
Plexus Ventures

The company provide business development services to clients in the pharmaceutical, biotechnology, consumer health, and drug delivery industries worldwide. The company's team members represent an array of nationalities and a mix of commercial, manufacturing, medical, and scientific expertise, gained from decades of experience with both global pharmaceutical and development-stage companies

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.